Stepped Treatment for Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior: A Randomized, Controlled Trial of Adjunctive Risperidone, Divalproex Sodium, or Placebo After Stimulant Medication Optimization

This study compared the efficacy in reducing aggressive behavior of risperidone (RISP), divalproex sodium (DVPX), and placebo (PBO) added to stimulant medication among children whose symptoms persisted after individually-optimized stimulant treatment.

Source: Journal of the American Academy of Child and Adolescent Psychiatry - January 29, 2020 Category: Psychiatry Authors: Joseph C. Blader, Steven R. Pliszka, Vivian Kafantaris, Carmel A. Foley, Gabrielle A. Carlson, Judith A. Crowell, Brigitte Y. Bailey, Colin Sauder, W. Burleson Daviss, Christa Sinha, Thomas L. Matthews, David M. Margulies Tags: New Research Source Type: research